Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children.

Whittaker E, López-Varela E, Broderick C, Seddon JA.

Front Pediatr. 2019 Jun 25;7:233. doi: 10.3389/fped.2019.00233. eCollection 2019. Review.

2.

The evolving research agenda for paediatric tuberculosis infection.

Seddon JA, Whittaker E, Kampmann B, Lewinsohn DA, Osman M, Hesseling AC, Rustomjee R, Amanullah F.

Lancet Infect Dis. 2019 Sep;19(9):e322-e329. doi: 10.1016/S1473-3099(18)30787-4. Epub 2019 Jun 17. Review.

PMID:
31221543
3.

The STREAM trial: missed opportunities and lessons for future clinical trials.

Loveday M, Reuter A, Furin J, Seddon JA, Cox H.

Lancet Infect Dis. 2019 Apr;19(4):351-353. doi: 10.1016/S1473-3099(19)30106-9. Epub 2019 Mar 22. No abstract available.

PMID:
30910428
4.

Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP.

Lancet. 2019 Mar 30;393(10178):1331-1384. doi: 10.1016/S0140-6736(19)30024-8. Epub 2019 Mar 20. Review. No abstract available.

PMID:
30904263
5.

Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis.

Osman M, Harausz EP, Garcia-Prats AJ, Schaaf HS, Moore BK, Hicks RM, Achar J, Amanullah F, Barry P, Becerra M, Chiotan DI, Drobac PC, Flood J, Furin J, Gegia M, Isaakidis P, Mariandyshev A, Ozere I, Shah NS, Skrahina A, Yablokova E, Seddon JA, Hesseling AC; Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR TB.

Emerg Infect Dis. 2019 Mar;25(3):441-450. doi: 10.3201/eid2503.180852.

6.

Using Changes in Weight-for-Age z Score to Predict Effectiveness of Childhood Tuberculosis Therapy.

Chiang SS, Park S, White EI, Friedman JF, Cruz AT, Del Castillo H, Lecca L, Becerra MC, Seddon JA.

J Pediatric Infect Dis Soc. 2019 Feb 1. doi: 10.1093/jpids/piy138. [Epub ahead of print]

PMID:
30715497
7.

The Wonder Years: What Can Primary School Children Teach Us About Immunity to Mycobacterium tuberculosis?

Seddon JA, Chiang SS, Esmail H, Coussens AK.

Front Immunol. 2018 Dec 13;9:2946. doi: 10.3389/fimmu.2018.02946. eCollection 2018. Review.

8.

Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).

Seddon JA, Garcia-Prats AJ, Purchase SE, Osman M, Demers AM, Hoddinott G, Crook AM, Owen-Powell E, Thomason MJ, Turkova A, Gibb DM, Fairlie L, Martinson N, Schaaf HS, Hesseling AC.

Trials. 2018 Dec 20;19(1):693. doi: 10.1186/s13063-018-3070-0.

9.

Global shortages of BCG vaccine and tuberculous meningitis in children.

du Preez K, Seddon JA, Schaaf HS, Hesseling AC, Starke JR, Osman M, Lombard CJ, Solomons R.

Lancet Glob Health. 2019 Jan;7(1):e28-e29. doi: 10.1016/S2214-109X(18)30474-1. No abstract available.

10.

Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant Tuberculosis.

Purchase SE, Garcia-Prats AJ, De Koker P, Draper HR, Osman M, Seddon JA, Schaaf HS, Hesseling AC.

Pediatr Infect Dis J. 2019 Jun;38(6):608-610. doi: 10.1097/INF.0000000000002268.

PMID:
30550511
11.

Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.

Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, Gendelman HE, Gordon R, Hesseling A, Le Van H, Kampmann B, Kana B, Khuller G, Lewinsohn DM, Lewinsohn DA, Lin PL, Lu LL, Maartens G, Owen A, Protopopova M, Rengarajan J, Rubin E, Salgame P, Schurr E, Seddon JA, Swindells S, Tobin DM, Udwadia Z, Walzl G, Srinivasan S, Rustomjee R, Nahid P.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):564-571. doi: 10.1164/rccm.201806-1053PP. No abstract available.

12.

Tuberculosis susceptibility and protection in children.

Basu Roy R, Whittaker E, Seddon JA, Kampmann B.

Lancet Infect Dis. 2019 Mar;19(3):e96-e108. doi: 10.1016/S1473-3099(18)30157-9. Epub 2018 Oct 12. Review.

13.

How practitioners integrate decision triggers with existing metrics in conservation monitoring.

Foster CN, O'Loughlin LS, Sato CF, Westgate MJ, Barton PS, Pierson JC, Balmer JM, Catt G, Chapman J, Detto T, Hawcroft A, Jones G, Kavanagh RP, McKay M, Marshall D, Moseby KE, Perry M, Robinson D, Seddon JA, Tuft K, Lindenmayer DB.

J Environ Manage. 2019 Jan 15;230:94-101. doi: 10.1016/j.jenvman.2018.09.067. Epub 2018 Sep 29.

PMID:
30273788
14.

Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study.

Dodd PJ, Yuen CM, Becerra MC, Revill P, Jenkins HE, Seddon JA.

Lancet Glob Health. 2018 Dec;6(12):e1329-e1338. doi: 10.1016/S2214-109X(18)30401-7. Epub 2018 Sep 25.

15.

The Changing Landscape of Childhood Tuberculosis in the United Kingdom: A Retrospective Cohort (2000-2015).

Mohiyuddin T, Seddon JA, Thomas HL, Lalor MK.

Pediatr Infect Dis J. 2019 May;38(5):470-475. doi: 10.1097/INF.0000000000002200.

PMID:
30256311
16.

Treatment of Multidrug-Resistant Tuberculosis Infection in Children.

Cruz AT, Garcia-Prats AJ, Furin J, Seddon JA.

Pediatr Infect Dis J. 2018 Oct;37(10):1061-1064. doi: 10.1097/INF.0000000000002135. No abstract available.

PMID:
30216296
17.

Time to act on injectable-free regimens for children with multidrug-resistant tuberculosis.

Seddon JA, Schaaf HS, Marais BJ, McKenna L, Garcia-Prats AJ, Hesseling AC, Hughes J, Howell P, Detjen A, Amanullah F, Singh U, Master I, Perez-Velez CM, Misra N, Becerra MC, Furin JJ.

Lancet Respir Med. 2018 Sep;6(9):662-664. doi: 10.1016/S2213-2600(18)30329-1. No abstract available.

18.

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.

Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC; Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB.

PLoS Med. 2018 Jul 11;15(7):e1002591. doi: 10.1371/journal.pmed.1002591. eCollection 2018 Jul.

19.

Treatment of Multidrug-resistant Tuberculosis Infection in Children.

Cruz AT, Garcia-Prats AJ, Furin J, Seddon JA.

Pediatr Infect Dis J. 2018 Aug;37(8):831-834. doi: 10.1097/INF.0000000000002087. Review. No abstract available.

20.

Statistical considerations for pediatric multidrug-resistant tuberculosis efficacy trials.

Kim S, Seddon JA, Garcia-Prats AJ, Montepiedra G.

Int J Tuberc Lung Dis. 2018 May 1;22(5):34-39. doi: 10.5588/ijtld.17.0358.

21.

Conducting efficacy trials in children with MDR-TB: what is the rationale and how should they be done?

Seddon JA, Weld ED, Schaaf HS, Garcia-Prats AJ, Kim S, Hesseling AC.

Int J Tuberc Lung Dis. 2018 May 1;22(5):24-33. doi: 10.5588/ijtld.17.0359.

22.

Effect of Coadministration of Lidocaine on the Pain and Pharmacokinetics of Intramuscular Amikacin in Children With Multidrug-Resistant Tuberculosis: A Randomized Crossover Trial.

Garcia-Prats AJ, Rose PC, Draper HR, Seddon JA, Norman J, McIlleron HM, Hesseling AC, Schaaf HS.

Pediatr Infect Dis J. 2018 Dec;37(12):1199-1203. doi: 10.1097/INF.0000000000001983.

23.

Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in children.

Schaaf HS, Garcia-Prats AJ, McKenna L, Seddon JA.

Expert Rev Clin Pharmacol. 2018 Mar;11(3):233-244. doi: 10.1080/17512433.2018.1421067. Epub 2017 Dec 27. Review.

24.

Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study.

Kampmann B, Seddon JA, Paton J, Nademi Z, Keane D, Williams B, Williams A, Liebeschutz S, Riddell A, Bernatoniene J, Patel S, Martinez N, McMaster P, Basu-Roy R, Welch SB.

Am J Respir Crit Care Med. 2018 Apr 15;197(8):1058-1064. doi: 10.1164/rccm.201707-1487OC.

25.

Correction to: The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study.

Golla V, Snow K, Mandalakas AM, Schaaf HS, Du Preez K, Hesseling AC, Seddon JA.

BMC Infect Dis. 2017 Nov 7;17(1):713. doi: 10.1186/s12879-017-2806-x.

26.

Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis.

Kodama C, Lange B, Olaru ID, Khan P, Lipman M, Seddon JA, Sloan D, Grandjean L, Ferrand RA, Kranzer K.

Eur Respir J. 2017 Oct 26;50(4). pii: 1701044. doi: 10.1183/13993003.01044-2017. Print 2017 Oct. No abstract available.

27.

Excellent Treatment Outcomes in Children Treated for Tuberculosis Under Routine Operational Conditions in Cape Town, South Africa.

Osman M, Lee K, Du Preez K, Dunbar R, Hesseling AC, Seddon JA.

Clin Infect Dis. 2017 Oct 16;65(9):1444-1452. doi: 10.1093/cid/cix602.

28.

The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?

Reuter A, Tisile P, von Delft D, Cox H, Cox V, Ditiu L, Garcia-Prats A, Koenig S, Lessem E, Nathavitharana R, Seddon JA, Stillo J, von Delft A, Furin J.

Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1114-1126. doi: 10.5588/ijtld.17.0468. Review.

PMID:
29037291
29.

The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study.

Golla V, Snow K, Mandalakas AM, Schaaf HS, Du Preez K, Hesseling AC, Seddon JA.

BMC Infect Dis. 2017 Aug 29;17(1):593. doi: 10.1186/s12879-017-2668-2. Erratum in: BMC Infect Dis. 2017 Nov 7;17(1):713.

30.

The global burden of tuberculosis mortality in children: a mathematical modelling study.

Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE.

Lancet Glob Health. 2017 Sep;5(9):e898-e906. doi: 10.1016/S2214-109X(17)30289-9.

31.

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.

Achar J, Hewison C, Cavalheiro AP, Skrahina A, Cajazeiro J, Nargiza P, Herboczek K, Rajabov AS, Hughes J, Ferlazzo G, Seddon JA, du Cros P.

Emerg Infect Dis. 2017 Oct;23(10). doi: 10.3201/eid2310.170303. Epub 2017 Oct 17.

32.

Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis.

Seddon JA, Schaaf HS.

Pneumonia (Nathan). 2016 Nov 24;8:20. doi: 10.1186/s41479-016-0019-5. eCollection 2016. Review.

33.

Management of child MDR-TB contacts across countries in the WHO European Region: a survey of current practice.

Turkova A, Tebruegge M, Brinkmann F, Tsolia M, Mouchet F, Kampmann B, Seddon JA.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):774-777. doi: 10.5588/ijtld.16.0949.

34.

Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature.

Swaminathan A, du Cros P, Seddon JA, Mirgayosieva S, Asladdin R, Dusmatova Z.

BMC Infect Dis. 2017 Jun 12;17(1):417. doi: 10.1186/s12879-017-2499-1. Review.

35.

If you look, you will find: time to challenge the childhood tuberculosis paradigm.

Seddon JA, Gie RP.

Int J Tuberc Lung Dis. 2017 Jun 1;21(6):602. doi: 10.5588/ijtld.17.0260. No abstract available.

36.

Reply to Raoult.

Seddon JA, Makhene MK, Gumbo T.

Clin Infect Dis. 2017 Apr 1;64(7):984. doi: 10.1093/cid/cix038. No abstract available.

37.

Linezolid for Children With Tuberculous Meningitis: More Evidence Required.

Basu Roy R, Seddon JA.

Pediatr Infect Dis J. 2017 Apr;36(4):439. doi: 10.1097/INF.0000000000001464. No abstract available.

38.

Standardized Methods for Enhanced Quality and Comparability of Tuberculous Meningitis Studies.

Marais BJ, Heemskerk AD, Marais SS, van Crevel R, Rohlwink U, Caws M, Meintjes G, Misra UK, Mai NTH, Ruslami R, Seddon JA, Solomons R, van Toorn R, Figaji A, McIlleron H, Aarnoutse R, Schoeman JF, Wilkinson RJ, Thwaites GE; Tuberculous Meningitis International Research Consortium.

Clin Infect Dis. 2017 Feb 15;64(4):501-509. doi: 10.1093/cid/ciw757. Review.

39.

The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis.

Dodd PJ, Prendergast AJ, Beecroft C, Kampmann B, Seddon JA.

Thorax. 2017 Jun;72(6):559-575. doi: 10.1136/thoraxjnl-2016-209421. Epub 2017 Jan 23. Review.

40.

Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities.

McAnaw SE, Hesseling AC, Seddon JA, Dooley KE, Garcia-Prats AJ, Kim S, Jenkins HE, Schaaf HS, Sterling TR, Horsburgh CR.

Int J Infect Dis. 2017 Mar;56:194-199. doi: 10.1016/j.ijid.2016.11.423. Epub 2016 Dec 9. Review.

41.

Why the Convention on the Rights of the Child must become a guiding framework for the realization of the rights of children affected by tuberculosis.

Basu Roy R, Brandt N, Moodie N, Motlagh M, Rasanathan K, Seddon JA, Detjen AK, Kampmann B.

BMC Int Health Hum Rights. 2016 Dec 8;16(1):32.

42.

New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations.

Harausz EP, Garcia-Prats AJ, Seddon JA, Schaaf HS, Hesseling AC, Achar J, Bernheimer J, Cruz AT, D'Ambrosio L, Detjen A, Graham SM, Hughes J, Jonckheere S, Marais BJ, Migliori GB, McKenna L, Skrahina A, Tadolini M, Wilson P, Furin J; Sentinel Project on Pediatric Drug-Resistant Tuberculosis.

Am J Respir Crit Care Med. 2017 May 15;195(10):1300-1310. doi: 10.1164/rccm.201606-1227CI. Review.

43.

Multidrug-resistant tuberculosis in children in northwest Russia: an observational cohort study.

Smirnova PA, Turkova A, Nikishova EI, Seddon JA, Chappell E, Zolotaya OA, Mironuk OM, Maryandyshev AO.

Eur Respir J. 2016 Nov;48(5):1496-1499. doi: 10.1183/13993003.00354-2016. Epub 2016 Sep 1. No abstract available.

44.

Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.

Garcia-Prats AJ, du Plessis L, Draper HR, Burger A, Seddon JA, Zimri K, Hesseling AC, Schaaf HS.

Int J Tuberc Lung Dis. 2016 Nov;20(11):1469-1476.

PMID:
27776587
45.

Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.

Gumbo T, Makhene MK, Seddon JA.

Clin Infect Dis. 2016 Nov 1;63(suppl 3):S110-S115. Review.

46.

Harnessing Novel Quantitative Pharmacology Approaches to Optimize the Treatment of Children With Tuberculosis.

Seddon JA, Makhene MK.

Clin Infect Dis. 2016 Nov 1;63(suppl 3):S61-S62. No abstract available.

47.

Knowing how many children to find is the first step in finding them.

Seddon JA.

Public Health Action. 2016 Jun 21;6(2):52. doi: 10.5588/pha.16.0040. No abstract available.

48.

Global burden of drug-resistant tuberculosis in children: a mathematical modelling study.

Dodd PJ, Sismanidis C, Seddon JA.

Lancet Infect Dis. 2016 Oct;16(10):1193-1201. doi: 10.1016/S1473-3099(16)30132-3. Epub 2016 Jun 21.

49.

The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection.

Seddon JA, Paton J, Nademi Z, Keane D, Williams B, Williams A, Welch SB, Liebeschutz S, Riddell A, Bernatoniene J, Patel S, Martinez-Alier N, McMaster P, Kampmann B.

Thorax. 2016 Oct;71(10):932-9. doi: 10.1136/thoraxjnl-2015-207687. Epub 2016 Jun 22.

50.

Two sizes do not fit all: the terms infection and disease are inadequate for the description of children with tuberculosis.

Seddon JA.

Arch Dis Child. 2016 Jul;101(7):594-5. doi: 10.1136/archdischild-2016-310747. Epub 2016 May 11. No abstract available.

Supplemental Content

Loading ...
Support Center